HCP5 and ovarian carcinoma: Recent studies demonstrated that HCP5 (human leukocyte antigen (HLA) complex 5) is a target gene of hMOF, and marked down-regulation of hMOF and HCP5, and loss of H4K16 acetylation were observed in ovarian epithelial cancer tissues [38, 43].